241 related articles for article (PubMed ID: 27625346)
1. Hypoglycemia in Frail Elderly Patients With Type 2 Diabetes Mellitus Treated With Sulfonylurea.
van Dijk P; Bouma A; Landman GW; Groenier KH; Bilo H; Kleefstra N; van Hateren KJ
J Diabetes Sci Technol; 2017 Mar; 11(2):438-439. PubMed ID: 27625346
[No Abstract] [Full Text] [Related]
2. [Not Available].
Viardot A
Ther Umsch; 2017; 74(8):423-431. PubMed ID: 29461148
[No Abstract] [Full Text] [Related]
3. Systematic review and meta-analysis of the efficacy and hypoglycemic safety of gliclazide versus other insulinotropic agents.
Chan SP; Colagiuri S
Diabetes Res Clin Pract; 2015 Oct; 110(1):75-81. PubMed ID: 26361859
[TBL] [Abstract][Full Text] [Related]
4. Is gliclazide a sulfonylurea with difference? A review in 2016.
Singh AK; Singh R
Expert Rev Clin Pharmacol; 2016 Jun; 9(6):839-51. PubMed ID: 26924475
[TBL] [Abstract][Full Text] [Related]
5. [Effect of short term hypoglycemic treatment with gliclazide and gliquidone on platelet function in patients with diabetes mellitus type II].
Grzeszczak W; Strojek K
Pol Tyg Lek; 1993 Apr; 48 Suppl 1():38-9. PubMed ID: 8516206
[No Abstract] [Full Text] [Related]
6. [Clinical evaluation of gliquidone--short acting sulfonylurea derivative--comparison with glibenclamide and gliclazide].
Rupprecht E; König E; Limmer J
Pol Tyg Lek; 1993 Apr; 48 Suppl 1():31-2. PubMed ID: 8516203
[No Abstract] [Full Text] [Related]
7. OBSTACLE hypoglycemia: Targeting a major hurdle in diabetes management!
Patell RD; Dosi RV
J Postgrad Med; 2014; 60(2):161-2. PubMed ID: 24937878
[No Abstract] [Full Text] [Related]
8. [Diamicron in the treatment of diabetes mellitus type 2].
Balabolkin MI; Morozova TP; Chachiashvili MV
Sov Med; 1987; (7):21-2. PubMed ID: 3317910
[No Abstract] [Full Text] [Related]
9. Authors' reply.
Kalra S; Singh V
J Postgrad Med; 2014; 60(3):344. PubMed ID: 25272399
[No Abstract] [Full Text] [Related]
10. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study.
Aravind SR; Ismail SB; Balamurugan R; Gupta JB; Wadhwa T; Loh SM; Suryawanshi S; Davies MJ; Girman CJ; Katzeff HL; Radican L; Engel SS; Wolthers T
Curr Med Res Opin; 2012 Aug; 28(8):1289-96. PubMed ID: 22738801
[TBL] [Abstract][Full Text] [Related]
11. Understanding correlation in the context of outliers.
Raina SK
J Postgrad Med; 2014; 60(3):343-4. PubMed ID: 25121385
[No Abstract] [Full Text] [Related]
12. Inadequacy of therapeutic education: a risk factor of hypoglycaemia.
Lepore C; Iacobellis G; Merante D; Antonucci G
Diabetes Res Clin Pract; 2003 Oct; 62(1):61-2. PubMed ID: 14581159
[No Abstract] [Full Text] [Related]
13. Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.
Holstein A; Hammer C; Hahn M; Kulamadayil NS; Kovacs P
Expert Opin Drug Saf; 2010 Sep; 9(5):675-81. PubMed ID: 20553106
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the micro- and macro-vascular effects of glimepiride and gliclazide in metformin-treated patients with Type 2 diabetes: a double-blind, crossover study.
Dhindsa P; Davis KR; Donnelly R
Br J Clin Pharmacol; 2003 Jun; 55(6):616-9. PubMed ID: 12814458
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects on lipids and lipoproteins of pioglitazone versus gliclazide addition to metformin and pioglitazone versus metformin addition to sulphonylurea in the treatment of type 2 diabetes.
Betteridge DJ; Vergès B
Diabetologia; 2005 Dec; 48(12):2477-81. PubMed ID: 16283239
[TBL] [Abstract][Full Text] [Related]
16. Comparison of efficacy, secondary failure rate, and complications of sulfonylureas.
Harrower AD
J Diabetes Complications; 1994; 8(4):201-3. PubMed ID: 7833494
[TBL] [Abstract][Full Text] [Related]
17. [Clinical efficacy of glimepiride].
Kaneko T; Sakamoto N
Nihon Rinsho; 1997 Nov; 55 Suppl():152-7. PubMed ID: 9434460
[No Abstract] [Full Text] [Related]
18. [Experience with diamicron treatment of diabetics].
Velikov VK; Shubina IO; Saltykov BB; Frolova AI
Klin Med (Mosk); 1984 Nov; 62(11):99-101. PubMed ID: 6441072
[No Abstract] [Full Text] [Related]
19. Neuroglycopenic Seizures: Sulfonylureas, Sulfamethoxazole, or Both?
Khan U; Seetharaman S; Merchant R
Am J Med; 2017 Jan; 130(1):e29-e30. PubMed ID: 27593606
[No Abstract] [Full Text] [Related]
20. Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
Bo S; Castiglione A; Ghigo E; Gentile L; Durazzo M; Cavallo-Perin P; Ciccone G
Eur J Endocrinol; 2013 Jul; 169(1):117-26. PubMed ID: 23660643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
